Pharmacogenomics and functional imaging to predict irinotecan pharmacokinetics and pharmacodynamics: the predict IR study.
Saved in:
| Title: | Pharmacogenomics and functional imaging to predict irinotecan pharmacokinetics and pharmacodynamics: the predict IR study. |
|---|---|
| Authors: | Michael M; Department of Medical Oncology, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia. Michael.Michael@petermac.org., Liauw W; Department of Medical Oncology, St. George's Hospital, Sydney, Australia., McLachlan SA; Department of Medical Oncology, St. Vincent's Hospital, Melbourne, Australia., Link E; Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Australia., Matera A; Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Australia., Thompson M; Division of Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia., Jefford M; Department of Medical Oncology, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia., Hicks RJ; Division of Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia., Cullinane C; Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia., Hatzimihalis A; Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia., Campbell IG; Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia., Rowley S; Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia., Beale PJ; Department of Medical Oncology, Royal Prince Alfred Hospital, Sydney, Australia., Karapetis CS; Department of Medical Oncology, Flinders Medical Centre, Flinders Centre for Innovation in Cancer, Adelaide, Australia., Price T; Department of Medical Oncology, The Queen Elizabeth Hospital, Adelaide, Australia., Burge ME; Department of Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, Australia. |
| Source: | Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2021 Jul; Vol. 88 (1), pp. 39-52. Date of Electronic Publication: 2021 Mar 23. |
| Publication Type: | Journal Article; Observational Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-0843 |
|---|---|
| DOI: | 10.1007/s00280-021-04264-8 |
